Organization
The Medicines Co.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
The Medicines Co.
... January 2018 - Celixir, a private company discovering and developing life-saving regenerative medicines, today announced it has received formal clinical trial application (CTA) approval from ...
... today announced the successful completion of its previously announced acquisition of The Medicines Company's (NASDAQ:MDCO) infectious disease business. "The completion of this acquisition marks yet ...
... The Medicines Company (NASDAQ:MDCO) today announced the closing of the sale of its infectious ...
... The Medicines Company (NASDAQ:MDCO) today announced that its Chief Executive Officer, Clive Meanwell, M.D., ...
... treatment of HER2-positive eBC was granted Priority Review,2 a designation given to medicines the FDA has determined to have the potential to provide significant improvements ...
... experience in the public healthcare arena, most recently as Executive Director of the Medicines Patent Pool, in Geneva. 'I am very pleased to have someone ...
... today's House of Commons Health Select Committee on 'Brexit: the regulation of medicines, medical devices and substances of human origin', the Association of the British ...
... WallStEquities.com has issued free tailored Stock Review on VSAR, AKRX, RIGL, and MDCO which is a click away athttp://www.wallstequities.com/registration. WallStEquities.com revisits the Generic Drugs market, ...
... The Medicines Company (NASDAQ:MDCO) today announced that it will host an Investor Day on ...
... companies and it's a realm where science is trying to develop landmark medicines that cure cancer, hepatitis and other life-threatening illnesses. Over the past few ...
... (NYSE:LCI), Oclaro, Inc. (NASDAQ:OCLR), Antares Pharma, Inc. (NASDAQ:ATRS), Workday, Inc. (NASDAQ:WDAY), The Medicines Company (NASDAQ:MDCO), and Celldex Therapeutics, Inc. (NASDAQ:CLDX), including updated fundamental summaries, consolidated ...
... MLNT) and up to $100 million in debt financing to The Medicines Company (NASDAQ: MDCO) in connection with Melinta's acquisition of the infectious disease business ...
... The Medicines Company (NASDAQ: MDCO) today announced that it has entered into a definitive agreement ...
... antibiotics to treat serious bacterial infections, today announced that Melinta and The Medicines Company (NASDAQ:MDCO) have entered into an agreement pursuant to which Melinta will ...
... kidney failure, will still need a doctor's prescription. Those taking certain "interacting" medicines will also be referred to a GP. "This decision is good news ...
... help clamp down on unregulated sales of the popular drug. "Erectile dysfunction medicines are a popular target for criminals selling unlicensed and counterfeit medicines," the ...
... specialty pharmaceutical company focused on becoming a leader in European specialty, off-patent medicines, today commented on the issuance by the UK Competition and Markets Authority ...
... a dozen biopharmaceutical companies. The hope: development of a new class of medicines that can mimic Pete's genes, to treat families like Millius', and the ...
... named company co-founder and Rhythm founder Bart Henderson CEO. FierceBiotech > The Medicines Company brought on former Pfizer executive Geno Germano to its board, and ...
... The Medicines Company (NASDAQ:MDCO) today announced that its Board of Directors has appointed Fredric ...
... The Medicines Company has tweaked its board, bringing former Pfizer executive Geno Germano in ...
... Geneva - The Medicines Patent Pool and the United States Agency for International Development (USAID) ...
... If you want a Stock Review on MDCO, MNTA, DPLO, or ZTS then come over tohttp://dailystocktracker.com/register/and sign up for your ...
Want to see the full history on The Medicines Co.? Upgrade to RelSci Pro now!
Start My Free Trial